If you’ve been researching fertility after 35, you’ve likely come across the term AMH — anti-Müllerian hormone. It’s become one of the most frequently ordered fertility tests, and it can feel like a high-stakes number. Understanding what AMH actually measures, what it can and can’t tell you, and how to interpret it in context can help remove some of the anxiety that often surrounds this test.
AMH is produced by small follicles in the ovaries and is considered a marker of ovarian reserve — the quantity of eggs remaining in your ovaries. But it’s not the whole picture of fertility, and a single number without clinical context can be misleading. This article explores what research says about AMH after 35 and how to approach it constructively.
For broader context on fertility testing and when to seek specialist care, our article on when to see a fertility specialist after 35 may be a helpful companion read.
What AMH Measures — and What It Doesn’t
According to research published through the NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, AMH reflects the quantity of small antral follicles in the ovaries, which correlates with overall egg count (ovarian reserve). Higher AMH is generally associated with a larger ovarian reserve; lower AMH with a smaller one.
However — and this is important — AMH measures quantity, not quality. Egg quality, which is equally important for successful conception, is largely determined by age and is not reflected in AMH levels. A woman with relatively high AMH at 38 still has age-related egg quality factors at play. Conversely, a woman with low AMH who is 36 may still conceive naturally, as some eggs of good quality may remain. AMH is one piece of a complex puzzle.
How AMH Levels Change After 35
AMH levels decline gradually from a peak in the mid-20s, accelerating somewhat in the late 30s and early 40s. This decline reflects the natural reduction in ovarian reserve that occurs with age. Research suggests there is significant variability between individuals — some women at 38 may have AMH levels similar to the average 32-year-old; others may have levels at the lower end for their age.
What “Low” AMH Actually Means in Practice
Clinicians and laboratories define “low” AMH differently, and reference ranges vary. Generally, AMH levels below about 1.0 ng/mL are considered low in fertility contexts, though interpretation depends on age, clinical history, and other test results like antral follicle count (AFC) on ultrasound. A low AMH level doesn’t mean pregnancy is impossible — it may mean that there are fewer eggs to work with, which can affect response to fertility medications in IVF but doesn’t necessarily predict natural conception rates.
What “Normal” or “High” AMH Means
A higher AMH relative to age is generally considered reassuring from a quantity standpoint, but high AMH can also sometimes be associated with polycystic ovary syndrome (PCOS) and should be interpreted in full clinical context. A high AMH in a 39-year-old doesn’t erase the age-related egg quality changes that come with that age.
AMH and Natural Conception After 35
One important finding from recent research is that AMH levels are not reliably predictive of natural conception rates in the general population. A widely-cited study published in the Journal of Clinical Endocrinology & Metabolism found that in women not undergoing fertility treatment, AMH levels were not significantly associated with time to conception. This finding has helped shift the view of AMH from a marker of “natural fertility” to more specifically a marker relevant to assisted reproduction contexts.
This doesn’t mean AMH is irrelevant to your fertility picture, but it suggests that a low AMH result alone — in the absence of other indicators — shouldn’t be read as “you cannot get pregnant.” Consulting with a reproductive endocrinologist can provide a more complete assessment.
The Full Fertility Picture: Beyond AMH
A comprehensive fertility evaluation typically includes AMH alongside antral follicle count (AFC) via transvaginal ultrasound, FSH and estradiol levels tested on day 2–4 of the cycle, and an evaluation of uterine anatomy. Male factor fertility is also assessed as part of a couple’s evaluation. Together, these provide a much richer picture than any single marker. If you’re concerned about your fertility after 35, requesting a full evaluation rather than focusing solely on AMH is advisable.
Our article on fertility testing after 35: what to expect covers the full evaluation process in more detail.
Frequently Asked Questions
Can I get my AMH tested by my regular OB/GYN?
Yes, AMH can typically be ordered by a general OB/GYN or primary care provider as a blood test. It can be tested at any point in the menstrual cycle (unlike some other hormones that require specific timing). However, interpretation of results is most meaningful in context — ideally alongside other fertility markers and with a provider who specializes in reproductive medicine.
Can I do anything to improve my AMH levels?
Current evidence does not support any well-established intervention that significantly raises AMH levels. Some small studies have looked at DHEA supplements and CoQ10 in the context of IVF outcomes, but evidence for these affecting AMH specifically is limited and inconsistent. Discussing any supplementation with your healthcare provider before starting is important, as individual suitability varies.
If my AMH is low, should I start fertility treatment immediately?
Not necessarily — this is a nuanced decision that depends on many factors including your age, how long you’ve been trying to conceive (if applicable), the rest of your fertility evaluation, and your personal circumstances. A reproductive endocrinologist can help you understand what a low AMH means specifically for your situation and what, if any, next steps make sense.
Does AMH predict when I’ll reach menopause?
Research suggests AMH may have some predictive value for timing of menopause, with lower levels associated with earlier menopause on average. However, prediction at an individual level is still imprecise, and this is an evolving area of research. AMH should not be interpreted as a definitive timeline for your reproductive future.
Key Takeaways
- AMH reflects ovarian reserve (egg quantity) but not egg quality — both are important for fertility, and quality is primarily influenced by age.
- AMH levels decline with age, with more pronounced changes often occurring after the mid-30s, but individual variation is significant.
- Research suggests AMH is not a reliable predictor of natural conception rates, making it most useful as a marker in assisted reproduction contexts rather than a verdict on your fertility.
- A full fertility evaluation — including AFC, FSH, estradiol, and uterine assessment — provides a much more complete picture than AMH alone.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.